# Cosmetic Challenge Testing: What the Results Tell You and How to Document the Decision

> Understand the scope of cosmetic challenge testing and connect sample identity, method suitability, report review, and the resulting product decision.

Canonical URL: https://cosmeticaffairs.com/blogs/cosmetic-chemistry/cosmetic-challenge-testing-decisions/

Author: [Cosmetic Affairs Editorial](https://cosmeticaffairs.com/authors/editorial/)
Published: 2026-10-17T00:00:00-04:00
Modified: 2026-10-17T00:00:00-04:00
Collection: Cosmetic Chemistry
Topics: Microbiology, Challenge Testing, Quality Control

![A laboratory technician uses a pipette near a cream sample and capped microbiology test tubes.](https://cosmeticaffairs.com/blogs/cosmetic-chemistry/cosmetic-challenge-testing-decisions/cover.png)

AI-generated illustration; not a photograph of actual laboratory work.

A challenge-test report has arrived and its conclusion appears favourable. Before the project moves forward, the team needs to establish what the report actually covers: the formula, sample, method, conditions and decision criteria.

That review connects the laboratory result to the product being developed. It also prevents a common documentation gap, where a report remains in an email while a formula continues to change elsewhere. Good records should make the relevance and limits of the evidence easy to see.

## Understand the question the test addresses

A preservation efficacy test evaluates how a formulation handles a defined microbial challenge under the selected test conditions. In broad terms, microorganisms are introduced and their survival is assessed over time. ISO 11930 covers preservation efficacy testing and the interpretation of testing and risk-assessment information when evaluating overall antimicrobial protection.[^1]

That question differs from examining the microbiological quality of a sample before use. FDA's Bacteriological Analytical Manual distinguishes microbiological findings for cosmetic products before use from preservative-efficacy considerations.[^2]

A favourable challenge-test result also does not describe every part of manufacturing hygiene. FDA identifies contaminated ingredients, poor manufacturing conditions, inadequate packaging, storage and consumer handling among potential routes of contamination.[^3]

These sources explain why a single report cannot stand for the whole control strategy. Keep challenge testing, relevant sample microbiology, manufacturing controls and product-use considerations connected, while recognising the different question each addresses.

## Establish the testing approach through risk assessment

Avoid starting with a rule that every cosmetic needs exactly the same test. ISO 29621 provides guidance for identifying finished products with a low microbiological risk on the basis of an assessment. ISO 11930 places its preservation efficacy test outside the scope for products assessed as microbiologically low risk using Annex A and ISO 29621.[^1][^4]

The practical task is to document the basis for the approach selected for the actual product. Ask the competent microbiologist or safety assessor what information is needed, which method is suitable and how the result will be interpreted in context.

Record who made the assessment, the product it covers and the evidence considered. If the proposed approach changes, keep the reason with the review. A short note such as “low risk” is difficult to use unless the underlying assessment can be retrieved.

For a development programme, make it clear whether work is exploratory or intended to support a final product decision. Different purposes should remain visible in the sample request and report.

## Give the laboratory an unambiguous sample history

Prepare a sample submission record before shipment. Identify the formula and version, the batch or laboratory preparation, the sample identifier, its preparation date and relevant storage history. Include information requested by the laboratory about composition, product type and intended use.

Agree the method, applicable edition, reporting scope and any planned modifications. Keep the commercial project name as an additional reference, rather than the only identifier. Names can remain unchanged while formulations evolve.

Ask the laboratory to acknowledge the sample identity and flag discrepancies. If its internal identifier differs from yours, preserve the mapping between them. Also record who will receive the final report and who is responsible for reviewing it.

These are suggested handoff practices. Their purpose is to make it possible to trace the result back to the material supplied and to resolve questions while the laboratory still has the relevant context.

## Review more than the conclusion line

Use a defined review checklist suited to the test commissioned. The following is a practical starting point for a technical reviewer, rather than a replacement for the method's reporting requirements.

| Review item | Question to resolve |
| --- | --- |
| Sample identity | Does the report match the submitted formula and preparation? |
| Method and edition | Was the agreed method used, with modifications identified? |
| Test coverage | Are the required organisms, assessment points and results addressed? |
| Method suitability | Are relevant validity checks and any limitations explained? |
| Interpretation | Which criteria support the laboratory's conclusion? |
| Deviations | Did any event affect the result or its interpretation? |
| Authorised report | Is this the issued report, with any later revision identifiable? |

For ISO 11930 work, neutralizer efficacy is one of the matters addressed by the method. Ask the laboratory to explain any qualification affecting interpretation; a low recovered count should not be interpreted without the relevant method context.[^1]

Where information is missing or unclear, record the question and the laboratory's response. Preserve the original issued report when a corrected version arrives, and identify which version supports the current decision.

## An illustrative result received after a formula change

Illustrative example: a fictional moisturiser's version 3 completes challenge testing. Before the report arrives, development creates version 4 with a different botanical ingredient and a changed target pH.

The report should stay linked to version 3. The team then asks whether its conclusion remains relevant to version 4 and what evidence would support that judgement. A competent reviewer considers the actual changes, the test findings and the broader assessment before deciding whether further work is needed.

The correct outcome is not predetermined by the version number. A numbering change alone does not establish a technical difference, while a small-looking formula edit still needs consideration. Document the rationale for the chosen action and identify who is responsible for completing it.

If additional testing is commissioned, link it to the earlier report and the change under review. The resulting history should explain how the team reached its decision, including evidence that did not support the preferred development route.

## Record the decision and keep it connected

A useful internal review states what the evidence supports, any remaining limitations and the next authorised step. It might support continuing development, require investigation or contribute to a broader product assessment. Record the reviewer, date and supporting report references.

When results are unfavourable, preserve them and investigate the relevant formulation, sample and method questions. If changes or justified repeat work follow, retain the connection to the original finding. Repeated testing should have a documented purpose and interpretation.

Make the final link explicit in the team's process: this report, for this sample and formula, was reviewed by this person and supports this decision. That is the information a future colleague needs when the product, supplier or manufacturing process changes.

## Sources

[^1]: International Organization for Standardization. [ISO 11930:2019 and Amendment 1:2022: Evaluation of the antimicrobial protection of a cosmetic product](https://www.iso.org/standard/75058.html). Public scope and available preview.

[^2]: US Food and Drug Administration. [Bacteriological Analytical Manual, Chapter 23: Methods for Cosmetics, July 2024](https://www.fda.gov/media/177960/download).

[^3]: US Food and Drug Administration. [Microbiological Safety and Cosmetics](https://www.fda.gov/cosmetics/potential-contaminants-cosmetics/microbiological-safety-and-cosmetics).

[^4]: International Organization for Standardization. [ISO 29621:2017: Risk assessment and identification of microbiologically low-risk products](https://www.iso.org/standard/68310.html). Public scope and available preview.